BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2106161)

  • 21. A continuous fluorescence assay of renin activity.
    Wang GT; Chung CC; Holzman TF; Krafft GA
    Anal Biochem; 1993 May; 210(2):351-9. PubMed ID: 8512070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
    Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
    J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N; Heath W; Osborne E; Lai M; Vlahos C
    Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs.
    Lam TL; Lam ML; Au TK; Ip DT; Ng TB; Fong WP; Wan DC
    Life Sci; 2000 Oct; 67(23):2889-96. PubMed ID: 11106004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases.
    Tözsér J; Bagossi P; Weber IT; Copeland TD; Oroszlan S
    J Biol Chem; 1996 Mar; 271(12):6781-8. PubMed ID: 8636100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive, hydrosoluble, macromolecular fluorogenic substrates for human immunodeficiency virus 1 proteinase.
    Anjuère F; Monsigny M; Lelièvre Y; Mayer R
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):869-73. PubMed ID: 8489513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
    Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
    Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates.
    Taliani M; Bianchi E; Narjes F; Fossatelli M; Urbani A; Steinkühler C; De Francesco R; Pessi A
    Anal Biochem; 1996 Aug; 240(1):60-7. PubMed ID: 8811880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV.
    Nashed NT; Louis JM; Sayer JM; Wondrak EM; Mora PT; Oroszlan S; Jerina DM
    Biochem Biophys Res Commun; 1989 Sep; 163(2):1079-85. PubMed ID: 2551268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous assay of the hydrolytic activity of human immunodeficiency virus-1 protease.
    Tyagi SC; Carter CA
    Anal Biochem; 1992 Jan; 200(1):143-8. PubMed ID: 1595889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-specific profiling of Plasmodium falciparum proteases using an internally quenched multispecificity protease substrate.
    Pattanaik P; Jain B; Ravindra G; Gopi HN; Pal PP; Balaram H; Balaram P
    Biochem Biophys Res Commun; 2003 Oct; 309(4):974-9. PubMed ID: 13679069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
    Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
    J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and implementation of a particle concentration fluorescence method for the detection of HIV-1 protease inhibitors.
    Manetta JV; Lai MH; Osborne HE; Dee A; Margolin N; Sportsman JR; Vlahos CJ; Yan SB; Heath WF
    Anal Biochem; 1992 Apr; 202(1):10-5. PubMed ID: 1621970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide substrates and inhibitors of the HIV-1 protease.
    Moore ML; Bryan WM; Fakhoury SA; Magaard VW; Huffman WF; Dayton BD; Meek TD; Hyland L; Dreyer GB; Metcalf BW
    Biochem Biophys Res Commun; 1989 Mar; 159(2):420-5. PubMed ID: 2649094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
    Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
    Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease.
    Tomaszek TA; Magaard VW; Bryan HG; Moore ML; Meek TD
    Biochem Biophys Res Commun; 1990 Apr; 168(1):274-80. PubMed ID: 2183799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.
    Bagossi P; Sperka T; Fehér A; Kádas J; Zahuczky G; Miklóssy G; Boross P; Tözsér J
    J Virol; 2005 Apr; 79(7):4213-8. PubMed ID: 15767422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer.
    Hu K; Clément JF; Abrahamyan L; Strebel K; Bouvier M; Kleiman L; Mouland AJ
    J Virol Methods; 2005 Sep; 128(1-2):93-103. PubMed ID: 15951029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
    Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
    Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.